You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Burkitt'S NHL

Showing 1 - 25 of 675
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Tumors Trial in Frankfurt (Adriamycin, Cyclophosphamide, Cytarabine)

Completed
  • Burkitt's Lymphoma
  • +4 more
  • Frankfurt, Germany
    University Hospital, Medical Dept. II
Aug 17, 2022

Grade 3a Follicular Lymphoma, Recurrent Burkitt Lymphoma, Recurrent DLBCL Trial in Atlanta, Columbus (other, drug, biological)

Recruiting
  • Grade 3a Follicular Lymphoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Atlanta, Georgia
  • +1 more
May 31, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Valhalla, New York
  • +1 more
Oct 29, 2021

Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)

Completed
Has Results
  • Non-Hodgkin Lymphoma
  • +8 more
  • La Jolla, California
  • +10 more
Apr 27, 2021

Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive

Active, not recruiting
  • Aggressive B-Cell Non-Hodgkin Lymphoma
  • fractionated first dose rituximab
  • Geneva, Switzerland
    University Hospital Geneva
Apr 21, 2023

Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

Recruiting
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 25, 2023

Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Recruiting
  • Diffuse Large Cell Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,

Recruiting
  • Follicular B-cell Non-Hodgkin's Lymphoma
  • +7 more
  • MB-106
  • Orange, California
  • +3 more
Nov 1, 2022

Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL) Trial in France (Real-life

Recruiting
  • Diffuse Large B Lymphoma (DLBCL)
  • +6 more
  • Real-life epidemiological platform of lymphoma in France
  • Arras, France
  • +36 more
Jun 25, 2021

Mature B-cell Non-Hodgkin Lymphoma Trial in Chengdu (Prednisone,Vincristine, Cyclophosphamide, Cyclophosphamide, Vincristine,

Active, not recruiting
  • Mature B-cell Non-Hodgkin Lymphoma
  • Prednisone,Vincristine, Cyclophosphamide
  • +5 more
  • Chengdu, Sichuan, China
    West China Second University Hospital of Sichuan University
Mar 17, 2022

Diffuse Large Cell Lymphoma, Burkitt's Lymphoma, High Grade B-cell Lymphoma Trial in United States (Rituximab, IT Cytarabine)

Completed
  • Diffuse Large Cell Lymphoma
  • +2 more
  • Buffalo, New York
  • +4 more
Oct 29, 2021

Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin Trial in Ann Arbor (Bortezomib, Ruxolitinib)

Completed
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
Dec 3, 2021

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Burkitt Lymphoma, Grade 1 Follicular Lymphoma,

Active, not recruiting
  • B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
  • +11 more
  • Atlanta, Georgia
  • +1 more
Apr 18, 2022

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • +12 more
    • Bedford, Bedfordshire, United Kingdom
    • +8 more
    Feb 22, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +11 more
    • Zilovertamab vedotin
    • Duarte, California
    • +13 more
    Jan 12, 2023

    Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma, Mantle Cell Lymphoma Trial in San Francisco (Fludarabine, Cyclophosphamide,

    Recruiting
    • Refractory Non-Hodgkin Lymphoma
    • +8 more
    • San Francisco, California
      University of California, San Francisco
    May 2, 2022

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    ALK-Positive Large B-Cell Lymphoma, Burkitt-Like Lymphoma With 11q Aberration, DLBCL Activated B-Cell Type Trial in United

    Active, not recruiting
    • ALK-Positive Large B-Cell Lymphoma
    • +34 more
    • Phoenix, Arizona
    • +32 more
    Jan 3, 2023

    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

    Recruiting
    • Acute Leukemia
    • +27 more
    • HSCT with TBI Regimen
    • HSCT with Non-TBI Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Apr 12, 2022

    Diffuse Large B-cell Lymphoma Trial (CHOP and BFM regiments)

    Completed
    • Diffuse Large B-cell Lymphoma
    • CHOP and BFM regiments
    • (no location specified)
    Jan 25, 2021

    B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

    Recruiting
    • B-cell Lymphoma
    • +8 more
    • Polatuzumab vedotin
    • Valhalla, New York
      New York Medical Center
    Oct 29, 2021

    B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in France, United States (XmAb13676)

    Recruiting
    • B-cell Non-Hodgkins Lymphoma
    • Chronic Lymphocytic Leukemia
    • XmAb13676
    • La Jolla, California
    • +21 more
    Oct 20, 2021

    AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the

    Active, not recruiting
    • AIDS-Related Burkitt Lymphoma
    • +5 more
    • Bethesda, Maryland
      NCI Lymphoid Malignancies Branch
    Jul 31, 2022

    Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

    Recruiting
    • Lymphoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in Worldwide

    Recruiting
    • B-Cell Non-Hodgkin Lymphoma
    • +2 more
    • Loncastuximab Tesirine
    • +4 more
    • Pembroke Pines, Florida
    • +19 more
    Jul 22, 2022